Clinical trials
Terminated Melanoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ABM Therapeutics Shanghai Company Limited | 1 |
| Bristol-Myers Squibb | 1 |
| Haihe Biopharma Co., Ltd. | 1 |
| Incyte Corporation | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Quanli Gao | 1 |
| Shenzhen Geno-Immune Medical Institute | 1 |
| Zai Lab (Shanghai) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 8 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
| Erdheim-Chester Disease | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.